ASX - By Stock
|
AN1 |
Re:
Evolis FGF5 - China Oppurtunity is Company Changing
|
|
mightypirate
|
1 |
759 |
2 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
1
|
759
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
2018 - The Year of the BioTechs
|
|
mightypirate
|
675 |
210K |
3 |
19/02/18 |
19/02/18 |
ASX - By Stock
|
675
|
210K
|
3
|
|
NZX - By Stock
|
AN1 |
Re:
Evolis Ingredients
|
|
mightypirate
|
11 |
3.3K |
1 |
19/02/18 |
19/02/18 |
NZX - By Stock
|
11
|
3.3K
|
1
|
|
NZX - By Stock
|
AN1 |
Re:
Evolis Ingredients
|
|
mightypirate
|
11 |
3.3K |
2 |
19/02/18 |
19/02/18 |
NZX - By Stock
|
11
|
3.3K
|
2
|
|
NZX - By Stock
|
AN1 |
Re:
Evolis Ingredients
|
|
mightypirate
|
11 |
3.3K |
5 |
18/02/18 |
18/02/18 |
NZX - By Stock
|
11
|
3.3K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
2018 - The Year of the BioTechs
|
|
mightypirate
|
675 |
210K |
2 |
16/02/18 |
16/02/18 |
ASX - By Stock
|
675
|
210K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Research: Midkine Causes Myocarditis-induced Heart Failure
|
|
mightypirate
|
10 |
3.7K |
2 |
07/02/18 |
07/02/18 |
ASX - By Stock
|
10
|
3.7K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine Symposium 2018
|
|
mightypirate
|
3 |
1.4K |
1 |
07/02/18 |
07/02/18 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
AN1 |
Research: Midkine Causes Myocarditis-induced Heart Failure
|
|
mightypirate
|
10 |
3.7K |
8 |
07/02/18 |
07/02/18 |
ASX - By Stock
|
10
|
3.7K
|
8
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Change of Director's Interest Notice-Halasz
|
|
mightypirate
|
60 |
27K |
6 |
04/02/18 |
04/02/18 |
ASX - By Stock
|
60
|
27K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
Pacific Edge Anticipating commercial growth
|
|
mightypirate
|
1 |
793 |
4 |
31/01/18 |
31/01/18 |
ASX - By Stock
|
1
|
793
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Nature Paper MK in Melanoma
|
|
mightypirate
|
53 |
20K |
2 |
27/01/18 |
27/01/18 |
ASX - By Stock
|
53
|
20K
|
2
|
|
ASX - By Stock
|
AN1 |
Research/Midkine: Effect of MK on gemcitabine resistance in biliary tract cancer
|
|
mightypirate
|
0 |
893 |
5 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
0
|
893
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Research: Midkine Controls Arteriogenesis by Regulating VEGFA Bioavailability and NOS Expression
|
|
mightypirate
|
4 |
1.6K |
5 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
4
|
1.6K
|
5
|
|
ASX - By Stock
|
AN1 |
Re:
Research: Midkine Controls Arteriogenesis by Regulating VEGFA Bioavailability and NOS Expression
|
|
mightypirate
|
4 |
1.6K |
3 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
4
|
1.6K
|
3
|
|
ASX - By Stock
|
AN1 |
Research: Midkine Controls Arteriogenesis by Regulating VEGFA Bioavailability and NOS Expression
|
|
mightypirate
|
4 |
1.6K |
3 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
4
|
1.6K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Appendix 4C - quarterly
|
|
mightypirate
|
7 |
4.3K |
10 |
25/01/18 |
25/01/18 |
ASX - By Stock
|
7
|
4.3K
|
10
|
|
ASX - By Stock
|
AN1 |
Re:
Bone Disorders: A Huge Market
|
|
mightypirate
|
11 |
4.0K |
11 |
24/01/18 |
24/01/18 |
ASX - By Stock
|
11
|
4.0K
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
Bone Disorders: A Huge Market
|
|
mightypirate
|
11 |
4.0K |
3 |
24/01/18 |
24/01/18 |
ASX - By Stock
|
11
|
4.0K
|
3
|
|
ASX - By Stock
|
AN1 |
Research/Midkine: Fracture Healing
|
|
mightypirate
|
4 |
1.2K |
4 |
24/01/18 |
24/01/18 |
ASX - By Stock
|
4
|
1.2K
|
4
|
|
ASX - By Stock
|
AN1 |
Re:
OUTSTANDING
|
|
mightypirate
|
78 |
27K |
10 |
23/01/18 |
23/01/18 |
ASX - By Stock
|
78
|
27K
|
10
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: CELLMID QUARTERLY OPERATIONAL UPDATE
|
|
mightypirate
|
39 |
15K |
2 |
18/01/18 |
18/01/18 |
ASX - By Stock
|
39
|
15K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: CELLMID QUARTERLY OPERATIONAL UPDATE
|
|
mightypirate
|
39 |
15K |
6 |
18/01/18 |
18/01/18 |
ASX - By Stock
|
39
|
15K
|
6
|
|
ASX - By Stock
|
AN1 |
Re:
The Huge Wool Market and FGF5(S)
|
|
mightypirate
|
16 |
6.3K |
1 |
13/01/18 |
13/01/18 |
ASX - By Stock
|
16
|
6.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
The Huge Wool Market and FGF5(S)
|
|
mightypirate
|
16 |
6.3K |
0 |
13/01/18 |
13/01/18 |
ASX - By Stock
|
16
|
6.3K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
The Huge Wool Market and FGF5(S)
|
|
mightypirate
|
16 |
6.3K |
1 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
16
|
6.3K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
The Huge Wool Market and FGF5(S)
|
|
mightypirate
|
16 |
6.3K |
2 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
16
|
6.3K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
The Huge Wool Market and FGF5(S)
|
|
mightypirate
|
16 |
6.3K |
1 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
16
|
6.3K
|
1
|
|
ASX - By Stock
|
AN1 |
The Huge Wool Market and FGF5(S)
|
|
mightypirate
|
16 |
6.3K |
9 |
12/01/18 |
12/01/18 |
ASX - By Stock
|
16
|
6.3K
|
9
|
|
ASX - By Stock
|
AN1 |
Research: Endog. Pleiotropin and Midkine Regulate LPS-induced Glial Responses
|
|
mightypirate
|
0 |
540 |
8 |
29/12/17 |
29/12/17 |
ASX - By Stock
|
0
|
540
|
8
|
|
ASX - By Stock
|
AN1 |
Anna Nordin: Midkine in Advanced Prostate Cancer
|
|
mightypirate
|
12 |
4.0K |
7 |
26/12/17 |
26/12/17 |
ASX - By Stock
|
12
|
4.0K
|
7
|
|
ASX - By Stock
|
AN1 |
Re:
Evolis display at Soul Pattinson Pitt St Sydney
|
|
mightypirate
|
21 |
9.4K |
7 |
21/12/17 |
21/12/17 |
ASX - By Stock
|
21
|
9.4K
|
7
|
|
ASX - By Stock
|
AN1 |
Clinical Study: Midkine In Multi-Biomarker Prognosis of ACS
|
|
mightypirate
|
8 |
4.1K |
3 |
21/12/17 |
21/12/17 |
ASX - By Stock
|
8
|
4.1K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cleansing Statement & Appendix 3B
|
|
mightypirate
|
12 |
4.0K |
3 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
12
|
4.0K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cleansing Statement & Appendix 3B
|
|
mightypirate
|
12 |
4.0K |
2 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
12
|
4.0K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cleansing Statement & Appendix 3B
|
|
mightypirate
|
12 |
4.0K |
1 |
19/12/17 |
19/12/17 |
ASX - By Stock
|
12
|
4.0K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Placement to Strategic Investor
|
|
mightypirate
|
50 |
21K |
14 |
15/12/17 |
15/12/17 |
ASX - By Stock
|
50
|
21K
|
14
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Placement to Strategic Investor
|
|
mightypirate
|
50 |
21K |
13 |
15/12/17 |
15/12/17 |
ASX - By Stock
|
50
|
21K
|
13
|
|
ASX - By Stock
|
AN1 |
Bone Disorders: A Huge Market
|
|
mightypirate
|
11 |
4.0K |
13 |
14/12/17 |
14/12/17 |
ASX - By Stock
|
11
|
4.0K
|
13
|
|
ASX - By Stock
|
AN1 |
Research/Autism: Midkine May Play Role in ASD Pathogenesis.
|
|
mightypirate
|
1 |
570 |
5 |
14/12/17 |
14/12/17 |
ASX - By Stock
|
1
|
570
|
5
|
|
ASX - By Stock
|
AN1 |
Research/Cancer: Midkine Promotes Tumour Cell Resistance to Cisplatin
|
|
mightypirate
|
0 |
458 |
11 |
13/12/17 |
13/12/17 |
ASX - By Stock
|
0
|
458
|
11
|
|
ASX - By Stock
|
AN1 |
Re:
Whats with the volumes?
|
|
mightypirate
|
5 |
1.9K |
0 |
17/11/17 |
17/11/17 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine Symposium 2018
|
|
mightypirate
|
3 |
1.4K |
2 |
16/11/17 |
16/11/17 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
AN1 |
Re:
New evolis video
|
|
mightypirate
|
4 |
1.4K |
1 |
15/11/17 |
15/11/17 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
AN1 |
Re:
Ann: Cellmid Presents at World Congress for Hair Research
|
|
mightypirate
|
5 |
1.9K |
3 |
14/11/17 |
14/11/17 |
ASX - By Stock
|
5
|
1.9K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Competition ???? LOL for Evolis
|
|
mightypirate
|
11 |
4.0K |
3 |
13/11/17 |
13/11/17 |
ASX - By Stock
|
11
|
4.0K
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine Study: Important Role in Pediatric Heart Failure
|
|
mightypirate
|
5 |
1.9K |
2 |
07/11/17 |
07/11/17 |
ASX - By Stock
|
5
|
1.9K
|
2
|
|
ASX - By Stock
|
AN1 |
Study: Midkine and NANOG as Biomarkers in OSCC
|
|
mightypirate
|
0 |
320 |
3 |
07/11/17 |
07/11/17 |
ASX - By Stock
|
0
|
320
|
3
|
|
ASX - By Stock
|
AN1 |
Re:
Midkine Study: Important Role in Pediatric Heart Failure
|
|
mightypirate
|
5 |
1.9K |
0 |
07/11/17 |
07/11/17 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
AN1 |
Midkine Study: Important Role in Pediatric Heart Failure
|
|
mightypirate
|
5 |
1.9K |
7 |
07/11/17 |
07/11/17 |
ASX - By Stock
|
5
|
1.9K
|
7
|
|